MADEDDU, GIORDANO
 Distribuzione geografica
Continente #
NA - Nord America 741
EU - Europa 453
AS - Asia 444
SA - Sud America 90
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 1
Totale 1.806
Nazione #
US - Stati Uniti d'America 695
RU - Federazione Russa 251
SG - Singapore 194
IT - Italia 104
CN - Cina 73
BR - Brasile 68
VN - Vietnam 63
BD - Bangladesh 34
KR - Corea 32
FR - Francia 28
CA - Canada 26
CI - Costa d'Avorio 21
NG - Nigeria 18
HK - Hong Kong 13
IN - India 12
GB - Regno Unito 10
MX - Messico 9
SE - Svezia 9
AR - Argentina 8
ES - Italia 8
PL - Polonia 8
JP - Giappone 7
DE - Germania 6
FI - Finlandia 5
IQ - Iraq 5
NL - Olanda 5
VE - Venezuela 4
ZA - Sudafrica 4
CL - Cile 3
CO - Colombia 3
ID - Indonesia 3
JM - Giamaica 3
UA - Ucraina 3
BG - Bulgaria 2
CR - Costa Rica 2
DK - Danimarca 2
EC - Ecuador 2
EG - Egitto 2
HU - Ungheria 2
IE - Irlanda 2
KE - Kenya 2
SN - Senegal 2
UZ - Uzbekistan 2
AL - Albania 1
AT - Austria 1
AU - Australia 1
BB - Barbados 1
BE - Belgio 1
BJ - Benin 1
BS - Bahamas 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
LB - Libano 1
MY - Malesia 1
NP - Nepal 1
PE - Perù 1
PK - Pakistan 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 1.780
Città #
Dallas 157
Moscow 131
Singapore 131
Santa Clara 94
San Jose 76
Ashburn 63
Los Angeles 44
Seoul 32
Council Bluffs 30
Beijing 24
New York 22
Abidjan 21
Lauterbourg 21
Ho Chi Minh City 20
Hefei 17
Rome 16
Abuja 15
Buffalo 13
Hong Kong 13
Rende 12
São Paulo 12
Catania 10
Hanoi 10
Montreal 10
Boston 8
Brooklyn 7
Denver 7
Tokyo 7
Warsaw 7
Houston 6
Mexico City 6
Milan 6
Orem 6
Phoenix 6
Toronto 6
Atlanta 5
Bologna 5
Chicago 5
London 5
San Francisco 5
Chennai 4
Johannesburg 4
Kochi 4
Lappeenranta 4
Misterbianco 4
Paris 4
Stockholm 4
Bastiglia 3
Madrid 3
Porto Alegre 3
Salvador 3
Santiago 3
Vancouver 3
Amsterdam 2
Austin 2
Bandung 2
Boardman 2
Brockton 2
Bắc Giang 2
Calgary 2
Caruaru 2
Copenhagen 2
Da Nang 2
Dublin 2
Guangzhou 2
Gütersloh 2
Haiphong 2
Ipirá 2
Kyiv 2
Manchester 2
Messina 2
Minneapolis 2
Nairobi 2
Norfolk 2
Nova Friburgo 2
Palermo 2
Parma 2
Port Harcourt 2
Quảng Ngãi 2
San Giovanni la Punta 2
Siena 2
Tashkent 2
Thái Nguyên 2
Turin 2
Abbeville 1
Afragola 1
Agawam 1
Ala 1
Almirante Brown 1
Amman 1
Anápolis 1
Arcoverde 1
Arlington 1
Aswān 1
Baghdad 1
Belle Mead 1
Belo Campo 1
Belo Horizonte 1
Bexley 1
Bismarck 1
Totale 1.215
Nome #
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists 148
Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance 118
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 99
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 90
Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 89
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results a large multicentre observational prospective cohort (SCOLTA) 87
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 82
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 77
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 76
Factors associated with weight gain in people treated with dolutegravir 76
Enhanced immunological recovery with early start of antiretroviral therapy during acute or early HIV infection–results of Italian network of acute HIV infection (Inaction) retrospective study 74
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 69
Weight gain: A possible side effect of all antiretrovirals 66
Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir 64
Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: The HIVand Hypertension Study 63
Safety and durability in a cohort of HIV-1 positive patients treated with once and twice daily darunavir-based therapy (SCOLTA Project) 57
Lipid profile improvement in virologically suppressed hiv-1-infected patients switched to dolutegravir/ abacavir/lamivudine: Data from the SCOLTA project 56
Efficacy of 1998 Vs 2006 first-line antiretroviral regimens for HIV infection: An ordinary clinics retrospective investigation 56
Impact of genotypic susceptibility score on cART outcomes during primary HIV infection 56
Novelties in evaluation and monitoring of human immunodeficiency virus-1 infection: Is standard virological suppression enough for measuring antiretroviral treatment success? 55
Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals 54
Efficacy and Safety of Cabotegravir–Rilpivirine in PLWH: A Real-World Study 53
Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort 49
Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort 46
Symmetric ambulatory arterial stiffness index and 24-h pulse pressure in HIV infection: Results of a nationwide cross-sectional study 46
Totale 1.806
Categoria #
all - tutte 5.914
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.914


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20233 0 0 0 0 0 0 0 0 3 0 0 0
2023/20242 0 0 0 0 0 1 0 0 0 0 0 1
2024/2025346 8 7 7 7 93 49 3 12 34 41 33 52
2025/20261.305 59 56 190 98 195 276 107 40 62 96 62 64
2026/2027150 111 39 0 0 0 0 0 0 0 0 0 0
Totale 1.806